BioSpace News Archive

Genetown

Novartis Delivers Strong Second Quarter and 50 Million CureVac Vaccines

The company also reported on its COVID-19 vaccine production with CureVac, a drug it is abandoning, and a few specific drug updates.

July 21, 2021
·
3 min read
·
Mark Terry
Policy

Koselugo: The First Non-Surgical Alternative for Rare Plexiform Neurofibroma

Notably, Koselugo was studied in pediatric populations first, a reversal of the typical development path taken by the majority of drugs.

July 21, 2021
·
5 min read
·
Heather McKenzie
Genetown

Albireo Breaks New Ground with Approvals for First Drug Bylvay in PFIC

It will immediately begin to sell Bylvay to treat patients impacted by PFIC, a rare cholestatic liver disease that often leads to cirrhosis and liver failure within the first ten years of life.

July 21, 2021
·
3 min read
·
Alex Keown
FDA

FDA Grants Breakthrough Device Designations to Endologix and NeuroMetrix

The U.S. Food and Drug Administration has recently granted Breakthrough Device Designation to two medical device companies, with California-based healthcare tech company Endologix leading the mix.

July 21, 2021
·
2 min read
·
Brandon May
KIYATEC Marks Glioblastoma Awareness Day by Initiating Use of 3D Predict™ Glioma Test Outside of Clinical Study

Functional precision oncology innovator KIYATEC announced today that it is initiating use of the 3D Predict™ Glioma test outside of its 3D-PREDICT clinical study

July 21, 2021
·
3 min read
Biotech Beach

Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences’ CAReS Study on July 28, 2021

Artelo Biosciences, Inc. today announced that Ladenburg Thalmann & Co. Inc. will host an R&D showcase focused on the Phase 1b/2a Cancer Appetite Recovery Study (“CAReS”), evaluating the Company’s lead drug candidate, ART27.13.

July 21, 2021
·
1 min read
KemPharm Announces U.S. Launch of Innovative ADHD Treatment AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules) by Corium, Inc.

KemPharm, Inc. today announced the U.S. commercial launch of AZSTARYS™

July 21, 2021
·
6 min read
Lone Star Bio

Cassava Sciences to Present New Clinical Dataset at 2021 Alzheimer’s Association International Conference

Cassava Sciences, Inc. today announced it will present two new clinical datasets for its product candidates at the 2021 Alzheimer’s Association International Conference July 26-30.

July 21, 2021
·
6 min read
Pharm Country

NHS Surgeon First in Europe to Implant TELA Bio’s OviTex® LPR Reinforced Tissue MatrixMr. Paul Wilson, Consultant General Surgeon, successfully completes complex hernia repair with minimally invasive approach

TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced today the first use of its OviTex LPR Reinforced Tissue Matrix in Europe.

July 21, 2021
·
5 min read
Deals

ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.

ArcScan, Inc. announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. (“Haohai”) that will result in a $11.15 million Preferred Series B investment into ArcScan, Inc.

July 21, 2021
·
4 min read